Is complement C1q a potential marker for tumor burden and immunodeficiency in multiple myeloma?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is complement C1q a potential marker for tumor burden and immunodeficiency in multiple myeloma?

Published:2019-01-10 Issue:7 Volume:60 Page:1812-1818
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Yang Ronghui¹^ORCID,Huang Jin²,Ma Huanxin¹,Li Shiwen¹,Gao Xin¹,Liu Yingshu³,Shen Jing¹,Liao Aijun¹

Affiliation:

1. Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China;

2. Department of Radiotherapy, The First Hospital of China Medical University, Shenyang, China;

3. Department of Laboratory, Shengjing Hospital of China Medical University, Shenyang, China

Funder

Natural Science Foundation of China

Shenyang Science and Technology

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2018.1543883

Reference16 articles.

1. NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018

2. Immunodeficiency and immunotherapy in multiple myeloma

3. The Classical Complement Pathway: Activation and Regulation of the First Complement Component

4. Complement proteins C1q and MBL are pattern recognition molecules that signal immediate and long-term protective immune functions

5. Structure and activation of the C1 complex of complement: unraveling the puzzle

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in the intestinal microbiota of multiple myeloma patients living in high‑altitude and cold regions analyzed using 16s rRNA high‑throughput sequencing;Experimental and Therapeutic Medicine;2024-04-29

2. The Depth of the Molecular Response in Patients with Chronic Myeloid Leukemia Correlates with Changes in Humoral Immunity;Journal of Clinical Medicine;2024-04-18

3. Absolute Quantification of Pan-Cancer Plasma Proteomes Reveals Unique Signature in Multiple Myeloma;Cancers;2023-09-28

4. Multi-omics investigation of the resistance mechanisms of pomalidomide in multiple myeloma;Frontiers in Oncology;2023-09-19

5. Harnessing the immunomodulatory effects of exercise to enhance the efficacy of monoclonal antibody therapies against B-cell haematological cancers: a narrative review;Frontiers in Oncology;2023-08-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3